受胎能検査および治療のヨーロッパ市場予測

◆英語タイトル:EUROPE FERTILITY TESTING AND TREATMENT MARKET FORECAST 2017-2023
◆商品コード:DATA611071
◆発行会社(調査会社):Inkwood Research
◆発行日:2016年11月
◆ページ数:65
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:ヨーロッパ
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可)USD1,950 ⇒換算¥218,400見積依頼/購入/質問フォーム
Multi LicenseUSD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Enterprisewide (Global Site License)USD4,000 ⇒換算¥448,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

KEY FINDINGS
Europe has the largest market share of In-vitro fertilization market. It pioneered the IVF technique and continuous research and development and investment has led to constant market growth. The global in-vitro fertilization market is poised to grow in 2017-2023 The various reasons for growth of the in-vitro fertilization market are increasing infertility across the world, delayed pregnancies, growing social acceptance of in-vitro fertilization, improving healthcare infrastructure and more awareness.
In-vitro fertilization refers to fertilization of egg with sperm outside the female body. It is a process the helps infertile couples have a child. WHO estimated that almost 25% couples in developing countries are infertile. There is a growing rate of infertility all over the globe. Reasons for infertility are increasing late marriages leading to higher maternal age, gynecological issues, growing incidences of obesity and addiction to alcohol, smoking and tobacco.

In-vitro fertilization market is segmented on the basis of geography, instruments, transfer techniques, procedure and end users. Various kinds of transfer techniques for IVF are fresh embryo transfer technique, frozen embryo transfer technique and donor egg transfer technique. IVF market is classified on the basis of IVF procedure and it can be either Intra cytoplasmic sperm injection (ICSI) or frozen embryo replacement (FER) or pre-implantation genetic diagnosis (PGD). IVF market is also classified on the basis of instruments used, which can be cryosystems, incubators, imaging systems, sperm separation systems, disposables and consumable ovum aspiration pump and others. End-users for IVF technology can be either hospitals or fertility clinics or surgical centers or clinical research institutes.

Market Insights
Market drivers for in-vitro fertilization are increasing rates of infertility all over the world, late pregnancies, social acceptance of in-vitro fertilization, growing awareness about this process, improving healthcare infrastructure and increase in healthcare expenditure.

Currently intra cytoplasmic sperm injection (ICSI) has the highest market share for IVF procedure and it is expected that it will continue to show good growth over the forecast period. Frozen embryo replacement (FER) will be the fastest growing segment during 2017-2023 due to higher success rates. FER has advantages like fewer miscarriages rate, increased implantation rate and low risk of pre-term labor.

Fresh non-donor embryo technique has the highest market share in the IVF market; IVF with ICSI is most widely used in case of fresh non-donor eggs followed by IVF without ICSI. Frozen non-donor market growth has the highest growth rate and will continue to have so in the forecast period. Fertility clinics are the largest end user accounting for 75% market share.

Factors that will restrain market growth are high costs associated with the procedure, low awareness in developing economies like Africa, ethical considerations and insufficient reimbursement policies for IVF treatment.

【レポートの目次】

1. RESEARCH SCOPE
1. STUDY GOALS
2. SCOPE OF THE STUDY MARKET AND FORECASTING YEARS

2. RESEARCH METHODOLOGY
1. SOURCES OF DATA
2. BOTTOM-UP APPROACH
3. TOP-DOWN APPROACH
4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY
1. MARKET SUMMARY & KEY FINDINGS OF THE STUDY

4. MARKET OVERVIEW
1. DRIVERS AND IMPACT
2. RESTRAIN AND IMPACT

5. MARKET BY COMPONENT TYPE
1. PRODUCTION SWITCHERS
2. ROUTER SWITCHERS
3. MASTER CONTROL SWITCHERS

6. MARKET BY END USER
1. SPORTS BROADCASTING MARKET
2. STUDIO PRODUCTION
3. PRODUCTION TRUCKS
4. NEWS PRODUCTION
5. POST PRODUCTION
6. OTHERS

7. MARKET BY TYPE OF PORT
1. COAXIAL
2. UNCOMPRESSED IP
3. COMPRESSED IP
4. OTHERS

8. KEY ANALYTICAL
1. 5 FORCES ANALYSIS
2. TOP THREE MARKET TRENDS
3. TOP THREE GEOGRAPHIES
4. MERGER AND ACQUISITIONS

9. REGIONAL ANALYSIS

10. NORTH AMERICA
1. US
2. CANADA
3. MEXICO

11. EUROPE
1. GERMANY
2. UK
3. RUSSIA
4. REST OF EUROPE (ROE)

12. ASIA PACIFIC (APAC)
1. CHINA
2. INDIA
3. SOUTH KOREA
4. REST OF ASIA PACIFIC (ROAPAC)

13. COMPETITIVE LANDSCAPE
1. BROADCAST PIX.INC
2. GRASS VALLEY USA, LLC
3. IKEGAMI ELECTRONICS U.S.A.
4. NEW TEC
5. PANASONIC CORPORATION
6. ROSS VIDEO LIMITED
7. SNELL LIMITED
8. SONY ELECTRONICS INC.
9. UTAH SCIENTIFIC, INC

[List of Tables]
1. EUROPE INFERTILITY TREATMENT MARKET BY GENDER 2016-2022 ($MILLION)
2. EUROPE AVERAGE COST COMPARISONS OF VARIOUS TREATMENTS
3. EUROPE MALE INFERTILITY TREATMENT MARKET IN $MILLION (2016-2022)
4. EUROPE MALE INFERTILITY TESTING MARKET IN $MILLION (2016-2022)
5. ADVANTAGES & DISADVANTAGES OF VARIOUS DNA SHEARING METHODS
6. EUROPE DNA FRAGMENTATION MARKET BY REGION, 2016-2022 (IN $MILLION)
7. EUROPE OXIDATIVE STRESS ANALYSIS MARKET BY REGION, 2016-2022 (IN $MILLION)
8. EUROPE SPERM PENETRATION ASSAY MARKET BY REGION, 2016-2022 (IN $MILLION)
9. EUROPE CASA MARKET, 2016-2022 (IN $MILLION)
10. EUROPE SPERM AGGLUTINATION MARKET BY REGION, 2016-2022 (IN $MILLION)
11. EUROPE MICROSCOPIC EXAMINATION MARKET BY REGION, 2016-2022 (IN $MILLION)
12. EUROPE FEMALE INFERTILITY TESTING MARKET, 2016-2022 (IN $MILLION)
13. EUROPE OVULATION TESTING MARKET BY REGION, 2016-2022 (IN $MILLION)
14. EUROPE HYSTEROSALPINGOGRAPHY MARKET, 2016-2022 (IN $MILLION)
15. EUROPE LAPAROSCOPY MARKET, 2016-2022 (IN $MILLION)
16. EUROPE TRANSVAGINAL ULTRASOUND MARKET (2016 - 2022) (IN $ MILLION)
17. EUROPE MARKET FOR OVARIAN RESERVE TESTING, 2016-2022 (IN $MILLION)
18. EUROPE IVF TREATMENT MARKET BY REGION, 2016-2022 (IN $MILLION)
19. EUROPE IUI TREATMENT MARKET BY REGION, 2016-2022 (IN $MILLION)
20. EUROPE DRUG AND HORMONE THERAPIES MARKET BY REGION, 2016-2022 (IN $MILLION)
21. EUROPE INFERTILITY TREATMENT MARKET, 2016-2022 (IN $MILLION)


[List of Figures]
1. MARKET SHARES OF INFERTILITY TREATMENT SEGMENTS, 2015
2. CAUSES OF INFERTILITY BASED ON GENDER
3. MAJOR FERTILITY TREATMENT DESTINATION RANKING
4. NUMBER OF IVF CYCLES PERFORMED IN THE US
5. UK INFERTILITY TREATMENT MARKET, 2016-2022 (IN $MILLION)
6. GERMANY INFERTILITY TREATMENT MARKET, 2016-2022 (IN $MILLION)
7. FRANCE INFERTILITY TREATMENT MARKET, 2016-2022 (IN $MILLION)
8. NORDICS INFERTILITY TREATMENT MARKET, 2016-2022 (IN $MILLION)
9. RUSSIA INFERTILITY TREATMENT MARKET, 2016-2022 (IN $MILLION)


【レポートのキーワード】

受胎能検査、治療

★調査レポート[受胎能検査および治療のヨーロッパ市場予測] (コード:DATA611071)販売に関する免責事項を必ずご確認ください。
★調査レポート[受胎能検査および治療のヨーロッパ市場予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆